Jane Street Group, LLC Natera, Inc. Call Options Transaction History

Jane Street Group, LLC

7 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	BUY	$97.75 - $129.67 $1.02 Million - $1.35 Million	10,400 New	10,400 $1.32 Million
Q1 2022 May 17, 2022	BUY	$30.32 - $91.33 $3.51 Million - $10.6 Million	115,700 Added 177.73%	180,800 $7.36 Million
Q4 2021 Feb 15, 2022	BUY	$86.26 - $119.0 $4.18 Million - $5.77 Million	48,500 Added 292.17%	65,100 $6.08 Million
Q3 2021 Nov 16, 2021	BUY	$100.17 - $126.36 $741,258 - $935,064	7,400 Added 80.43%	16,600 $1.85 Million
Q2 2021 Aug 16, 2021	BUY	$86.05 - $119.72 $550,720 - $766,208	6,400 Added 228.57%	9,200 $1.04 Million
Q1 2021 May 18, 2021	SELL	$91.47 - $124.36 $1.49 Million - $2.03 Million	-16,300 Reduced 85.34%	2,800 $284,000
Q3 2020 Nov 17, 2020	BUY	$45.89 - $72.67 $876,499 - $1.39 Million	19,100 New	19,100 $1.38 Million

526

119M

308K

191K

Ticker NTRA
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 96,957,400
Market Cap $14.2B
Description
Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify sing...

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Jane Street Group, LLC with notifications on news.